Metastatic HER2-Negative Breast Cancer
1 clinical trials · Condition
◉ Watch Metastatic HER2-Negative Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Study of JSKN016 Combination Therapy in Inoperable Locally Advanced or Metastatic HER2-Negative Breast Cancer (NCT06942234) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2025-06-01 |
Track Metastatic HER2-Negative Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.